Sara Gandolfi

1.2k total citations
28 papers, 491 citations indexed

About

Sara Gandolfi is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Sara Gandolfi has authored 28 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Hematology and 7 papers in Oncology. Recurrent topics in Sara Gandolfi's work include Multiple Myeloma Research and Treatments (14 papers), Protein Degradation and Inhibitors (8 papers) and Immune Cell Function and Interaction (5 papers). Sara Gandolfi is often cited by papers focused on Multiple Myeloma Research and Treatments (14 papers), Protein Degradation and Inhibitors (8 papers) and Immune Cell Function and Interaction (5 papers). Sara Gandolfi collaborates with scholars based in United States, Italy and Finland. Sara Gandolfi's co-authors include Paul G. Richardson, Jacob P. Laubach, Kenneth C. Anderson, Dharminder Chauhan, Teru Hideshima, Constantine S. Mitsiades, Michal Sheffer, Geoffrey M. Matthews, Olga Dashevsky and Ricardo De Matos Simoes and has published in prestigious journals such as Blood, Cancer Research and British Journal of Haematology.

In The Last Decade

Sara Gandolfi

26 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Gandolfi United States 10 328 247 172 66 48 28 491
Lenka Bešše Switzerland 12 248 0.8× 186 0.8× 121 0.7× 57 0.9× 56 1.2× 39 399
Tami Rashal United States 8 474 1.4× 220 0.9× 220 1.3× 100 1.5× 37 0.8× 31 639
Hanne Hella Norway 11 374 1.1× 158 0.6× 121 0.7× 36 0.5× 55 1.1× 18 554
Barbara Szymanska Australia 6 306 0.9× 125 0.5× 140 0.8× 46 0.7× 75 1.6× 7 499
Zohar Sachs United States 12 246 0.8× 138 0.6× 83 0.5× 42 0.6× 73 1.5× 36 383
Michelle F. Waldman United States 6 441 1.3× 306 1.2× 265 1.5× 92 1.4× 104 2.2× 14 653
Taku Tsukamoto Japan 10 162 0.5× 99 0.4× 116 0.7× 83 1.3× 44 0.9× 50 304
Iris Appelmann Germany 11 236 0.7× 108 0.4× 70 0.4× 34 0.5× 55 1.1× 22 438
Kathryn J. Newhall United States 14 225 0.7× 131 0.5× 288 1.7× 56 0.8× 153 3.2× 25 535
Takahiko Yasuda Japan 12 269 0.8× 131 0.5× 79 0.5× 39 0.6× 93 1.9× 33 465

Countries citing papers authored by Sara Gandolfi

Since Specialization
Citations

This map shows the geographic impact of Sara Gandolfi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Gandolfi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Gandolfi more than expected).

Fields of papers citing papers by Sara Gandolfi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Gandolfi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Gandolfi. The network helps show where Sara Gandolfi may publish in the future.

Co-authorship network of co-authors of Sara Gandolfi

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Gandolfi. A scholar is included among the top collaborators of Sara Gandolfi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Gandolfi. Sara Gandolfi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klievink, Jay, Hanna Lähteenmäki, Emmi Jokinen, et al.. (2024). Bone Marrow Stromal Cells Hamper Leukemia Cell Induced NK Cell Activation and Cytotoxicity. Blood. 144(Supplement 1). 4814–4814. 2 indexed citations
2.
Dashevsky, Olga, Ricardo De Matos Simoes, Benjamin G. Barwick, et al.. (2021). Functional Genomic and Immune Response Characterization of PTEN Loss: Therapeutic Implications for Myeloma. Blood. 138(Supplement 1). 1612–1612.
3.
Gandolfi, Sara, Olli Dufva, Jani Huuhtanen, et al.. (2021). Functional Genomic Landscape of Natural Killer Cell Evasion in Multiple Myeloma. Blood. 138(Supplement 1). 732–732. 2 indexed citations
4.
Gandolfi, Sara, Olli Dufva, Jani Huuhtanen, et al.. (2021). OAB-019: CRISPR screens with single-cell transcriptome readout reveal potential mechanisms of response to natural killer cell treatment in multiple myeloma. Clinical Lymphoma Myeloma & Leukemia. 21. S12–S13. 1 indexed citations
5.
Varga, Cindy, Johannes M. Waldschmidt, Sara Gandolfi, & Paul G. Richardson. (2020). Current antibody-based therapies for the treatment of multiple myeloma.. PubMed. 18(11). 736–748. 1 indexed citations
6.
Dashevsky, Olga, Ricardo De Matos Simoes, Ryosuke Shirasaki, et al.. (2020). Use of Olfactory Receptor Genes As Controls for Genome-Scale CRISPR Functional Genomic Studies to Define Treatment Resistance Mechanisms. Blood. 136(Supplement 1). 36–36.
7.
Gandolfi, Sara, Michal Sheffer, Olga Dashevsky, et al.. (2019). Molecular markers of MM cell sensitivity and resistance to Natural Killer cells: implications for anti-MM immunotherapy. Clinical Lymphoma Myeloma & Leukemia. 19(10). e168–e169. 1 indexed citations
8.
Dufva, Olli, Khalid Saeed, Sara Gandolfi, et al.. (2019). CRISPR Screens Identify Mechanisms of Natural Killer Cell Evasion across Blood Cancers. Blood. 134(Supplement_1). 3597–3597. 3 indexed citations
9.
Gandolfi, Sara, et al.. (2018). How I treat the young patient with multiple myeloma. Blood. 132(11). 1114–1124. 33 indexed citations
10.
Gandolfi, Sara, Jacob P. Laubach, Teru Hideshima, et al.. (2018). The power of proteasome inhibition in multiple myeloma. Expert Review of Proteomics. 15(12). 1033–1052. 29 indexed citations
11.
Tang, Huihui, Ricardo De Matos Simoes, Ryosuke Shirasaki, et al.. (2018). CRISPR Activation Screen for HDAC Inhibitor Resistance. Blood. 132(Supplement 1). 3958–3958. 1 indexed citations
12.
Shirasaki, Ryosuke, Sara Gandolfi, Ricardo De Matos Simoes, et al.. (2018). Abstract 2834: Genomewide CRISPR studies of sequential treatment with CRBN-based degronimids: Insights into the molecular evolution of treatment resistance in myeloma and beyond. Cancer Research. 78(13_Supplement). 2834–2834. 1 indexed citations
13.
Gandolfi, Sara, Olga Dashevsky, Ricardo De Matos Simoes, et al.. (2017). Long-Term Interactions with Bone Marrow Stromal Cells Alter the Molecular Dependencies of Myeloma Cells: Insights from Genomewide CRISPR-Based Functional Genomic Screens. Blood. 130. 3028–3028. 1 indexed citations
14.
Gandolfi, Sara, Jacob P. Laubach, Teru Hideshima, et al.. (2017). The proteasome and proteasome inhibitors in multiple myeloma. Cancer and Metastasis Reviews. 36(4). 561–584. 257 indexed citations
15.
Matthews, Geoffrey M., Sara Gandolfi, Ricardo De Matos Simoes, et al.. (2016). BET Bromodomain Degradation As a Therapeutic Strategy in Multiple Myeloma. Blood. 128(22). 1062–1062. 3 indexed citations
16.
Matthews, Geoffrey M., Ricardo De Matos Simoes, Eugen Dhimolea, et al.. (2016). NF-κB dysregulation in multiple myeloma. Seminars in Cancer Biology. 39. 68–76. 43 indexed citations
17.
Castagna, Luca, Roberto Crocchiolo, Laura Giordano, et al.. (2015). High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant. Bone Marrow Transplantation. 50(4). 499–504. 6 indexed citations
18.
19.
Carlo‐Stella, Carmelo, Richard Delarue, Prajak J. Barde, et al.. (2015). A Dose Escalation Study of RP6530, a Novel Dual PI3K Delta/Gamma Inhibitor, in Patients with Relapsed/Refractory Hematologic Malignancies. Blood. 126(23). 1495–1495. 2 indexed citations
20.
Sala, Elisa, Roberto Crocchiolo, Sara Gandolfi, et al.. (2014). Bendamustine Combined with Donor Lymphocytes Infusion in Hodgkin's Lymphoma Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 20(9). 1444–1447. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lenka Bešše Breakdown of academic impact, for papers by Tami Rashal Breakdown of academic impact, for papers by Hanne Hella Breakdown of academic impact, for papers by Barbara Szymanska Breakdown of academic impact, for papers by Zohar Sachs Breakdown of academic impact, for papers by Michelle F. Waldman Breakdown of academic impact, for papers by Taku Tsukamoto Breakdown of academic impact, for papers by Iris Appelmann Breakdown of academic impact, for papers by Kathryn J. Newhall Breakdown of academic impact, for papers by Takahiko Yasuda
Rankless by CCL
2026